ARX-424

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameARX-424
Drug Alias NameARX-424
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionInterferon beta stimulants
TargetsInterferon beta
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAmbrx Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmbrx IncMerck Serono
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A